Warren Buffett's Berkshire Hathaway sharply increased its stake in ConocoPhillips this spring and summer, accumulating a total of 84 million shares as of the end of the third quarter on September 30, according to Berkshire's just-released quarterly portfolio filing with the SEC.    Read More

Warren Buffett has very publicly proclaimed that now is the time to be "greedy" and buy U.S. stocks, because everyone else is fearful, and those fears are driving down stock prices to bargain levels.  While some praise his leadership and courage, there are also skeptics.    Read More

Eli Lilly has been running direct-to-doctor ads over the past few months telling physicians that Effient, the company's new bloodthinner, is "Coming Soon". Well, it may have jumped the gun.    Read More

Today is the day the FDA is expected to make a decision on the drug. The agency could approve it outright, approve it with conditions/limitations, delay making a decision--again--and order more tests, or reject the pill.   Read More

New Eli Lilly CEO John Lechleiter today joins the list of the recent fresh crop of big pharma honchos who've been elevated to Chairman of the Board as well. But that's not what's moving shares of LLY higher this morning.    Read More

Of all the places to put money to work in Europe, the pharmaceutical sector is the most promising, a technical analyst told CNBC Thursday.   Read More

You're never too young to pick stocks, and 21-year-old Laura Bordelon is living -- and investing -- proof. She's portfolio manager of the Green and Gold Fund, although she's just started her senior year at the University of Alabama at Birmingham.   Read More

Warren Buffett's Berkshire Hathaway has added a new stake in NRG Energy, according to a just-released portfolio 'snapshot' of its holdings in U.S. publicly-traded stocks as of June 30.  A sharply reduced stake in Anheuser-Busch may have been a bet that InBev's initially unsolicited offer for the U.S. brewer would prove to be unsuccessful.  Conoco-Phillips data is kept "confidential."   Read More

The market cap of Dow component Johnson & Johnson is a whopping $200 billion. Abbott Labs is valued at less than half that. But think of ABT as kind of a mini-me JNJ because like Johnson & Johnson, ABT has cobbled together a similar three-siloed business of drugs, devices and consumer products.    Read More

After taking the lead in the qualifying rounds, France's CAC 40 is now in sixth place in our World Markets Challenge.  YTD the index is down over 19%.  Here are some key stats on France's economy and markets.   Read More